Location History:
- L'Aquila AQ, IT (2010)
- L'Aquila, IT (2004 - 2016)
- Milan, IT (2016)
Company Filing History:
10 out of 14 
7 out of 22 
3 out of 49 
Years Active: 2004-2024
Title: Maria Candida Cesta: A Leader in Urological Innovations
Introduction
Maria Candida Cesta is an accomplished inventor based in L'Aquila, Italy, known for her significant contributions to the field of urological treatments. With a remarkable portfolio of 25 patents, she has established herself as a leading figure in medical innovations aimed at improving patient care and outcomes.
Latest Patents
Among her latest patents is a groundbreaking invention concerning IL-8 inhibitors for the treatment of various urological disorders. This invention pertains to IL-8 inhibitor compounds, specifically dual CXCR1/CXCR2 receptor inhibitors, designed for the treatment and prevention of conditions such as interstitial cystitis/painful bladder syndrome (IC/PBS) and overactive bladder (OAB). The patent extends to methods of treatment and prevention, as well as combinations and kits that incorporate these IL-8 inhibitors.
Another notable patent involves omega-aminoalkylamides of R-2-aryl-propionic acids, recognized as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells. This innovation outlines (R)-2-arylpropionamide compounds and their pharmaceutical preparations, intended for preventing and treating tissue damage associated with excessive recruitment of immune cells at inflammatory sites. Particularly, these compounds serve as dual inhibitors of C5a-induced and IL-8-induced chemotaxis, showcasing their potential in managing inflammatory responses.
Career Highlights
Maria has played a vital role in developmental work for eminent companies, particularly within Dompé Pharma S.p.A. and Dompé S.p.A. Her expertise in pharmacological research has led to significant advancements in therapeutic approaches to urological disorders, aided by her extensive patent portfolio.
Collaborations
Throughout her career, Maria has collaborated with renowned professionals such as Marcello Allegretti and Riccardo Bertini. These collaborations have enriched her research endeavors and resulted in impactful innovations within the pharmaceutical landscape.
Conclusion
Maria Candida Cesta exemplifies dedication and ingenuity in the realm of medical innovations. Her patented inventions not only enhance treatment options for patients suffering from urological disorders but also contribute significantly to the broader field of pharmacology. As she continues to advance her research, the medical community eagerly anticipates her future contributions.